Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Aakaar Medical Techn IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2013 Industry: Trading Listed Page

Profile
Issue Size 19.32 Cr
Profile
Price Range 68  to  72 per share
Profile
Min Investment ₹72
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

“Aakaar Medical Technologies Private Limited” was incorporated in the year 2013 under the leadership of Mr. Dilip Meswani who has been in the Aesthetic business since more than 25 years. He commenced his journey in the aesthetics business in 1999 through a proprietary business which was primarily selling Aesthetic Devices and then shifted his entire business under Aakaar Medical Technologies Private Limited. Read More

Basic Info

Face Value 10 per share

Price 68  to  72 per share

P/E (x) 11.8

Sales( Cr.) 62

PAT( Cr.) 6

EPS 6.1

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Dilip Ramesh Meswani Bindi Dilip Meswani

Pre Issue Share Holding 91.11%

Post Issue Share Holding 67.05%

Listing Details:

Listing Price: 75

Listing Gain: 4%

Current Price: 82

Gain On Issue: 82 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Jun 20, 2025
Closing Date Jun 24, 2025
Allotment Jun 25, 2025
Refund Jun 26, 2025
Delivery of Shares Jun 26, 2025
Listing Date Jun 27, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1600 115,200
Retail (Max) 1 1600 115,200
S-HNI (Min) 2 3200 230,400
S-HNI (Max) 8 12800 921,600
B-HNI (Min) 9 14400 1,036,800

Objective of the Issue

1. Funding working capital requirements of our Company 2. General corporate purposes.

Issue

Category Nos Bid Bid (x)
QIB 0 2496000 0x
NII 0 982400 0x
Retail 0 2411200 0x
EMP 0 0 0x
Total 0 5889600 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Aakaar Medical Techn Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 19 33 46 62
Other Income 0 0 0 0
Total Income 20 33 46 62
Total Expenditure 17 29 41 52
Operating Profit 2 4 5 10
Interest 0 0 1 2
Depreciation 0 0 0 0
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 2 3 4 8
Provision for Tax 1 1 1 2
Profit After Tax 2 2 3 6
Adjustments 0 0 0 0
Profit After Adjustments 2 2 3 6
Adjusted Earnings Per Share 1.7 2.3 3 5.8

Aakaar Medical Techn Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 8 10 13 23
Minority's Interest 0 0 0 0
Borrowings 0 0 0 0
Other Non-Current Liabilities 0 0 2 3
Total Current Liabilities 9 13 21 30
Total Liabilities 18 23 35 56
Fixed Assets 0 0 0 0
Other Non-Current Assets 0 0 2 4
Total Current Assets 17 22 33 52
Total Assets 18 23 35 56

Aakaar Medical Techn Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 3 2 0 0
Cash Flow from Operating Activities 0 -3 -8 -5
Cash Flow from Investing Activities -0 -0 -0 -0
Cash Flow from Financing Activities -1 1 8 11
Net Cash Inflow / Outflow -1 -2 0 5
Closing Cash & Cash Equivalent 2 0 0 6

Aakaar Medical Techn Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.69 2.25 3 5.79
CEPS(Rs) 1.72 2.35 3.15 5.91
DPS(Rs) 0.59 0.55 0 0
Book NAV/Share(Rs) 8.4 10.11 13.11 22.26
Core EBITDA Margin(%) 12.31 10.76 10.84 15.81
EBIT Margin(%) 12.42 10.78 10.89 15.9
Pre Tax Margin(%) 11.32 9.46 8.43 13.12
PAT Margin (%) 8.31 6.57 6.22 9.81
Cash Profit Margin (%) 8.43 6.84 6.52 10.01
ROA(%) 9.09 10.56 9.94 13.35
ROE(%) 20.16 24.35 25.88 33.81
ROCE(%) 20.4 25.81 23.29 26.62
Receivable days 104.45 87.97 104.87 131.18
Inventory Days 131.22 101.6 100.66 85.15
Payable days 65.1 50.42 37.89 37.08
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.12 0.19 0.34 0.45
EV/Core EBITDA(x) 0.92 1.76 3 2.78
Net Sales Growth(%) 0 68.43 40.65 33.55
EBIT Growth(%) 0 46.18 42.17 94.91
PAT Growth(%) 0 33.04 33.3 110.42
EPS Growth(%) 0 33.04 33.3 92.91
Debt/Equity(x) 0.48 0.61 1.2 0.98
Current Ratio(x) 1.83 1.72 1.59 1.73
Quick Ratio(x) 1.09 0.85 0.9 1.25
Interest Cover(x) 11.32 8.21 4.42 5.73
Total Debt/Mcap(x) 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 35% 48% 0% 0%
Operating Profit CAGR 100% 71% 0% 0%
PAT CAGR 100% 44% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 34% 28% 26% 26%
ROCE Average 27% 25% 24% 24%

Company Contact Information

Aakaar Medical Technologies Ltd.

Anoopkumar Vishwanathan Pillai

+91 84528 44024

companysecretary@aakaarmedical.in

IPO Lead Manager(s)

Aakaar Medical Technologies Ltd.

Indorient Financial Services Ltd.

Registrar Info

Aakaar Medical Technologies Ltd.

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093 (old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059 Tel: + 91 21 626 38200 Fax:

91-022-62638200

91-022-62638299

Investor@bigshareonline.com

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!